Skip to content

Clinical trials

Sleep Apnea, Obstructive trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Apnea, Obstructive Country / region: Netherlands Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20101
20121
20131
20141
20152
20163
20171
20181
20192
20201
20211
20221
20231
20243
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status5
Not yet recruiting3
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)6
Rijnstate Hospital4
Academic Centre for Dentistry in Amsterdam3
Inspire Medical Systems, Inc.3
Jazz Pharmaceuticals3
Axsome Therapeutics, Inc.1
Diakonessenhuis, Utrecht1
Nyxoah S.A.1
Revent Medical International B.V.1
Signifier Medical Technologies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Apnea, Obstructive26
Sleep Apnea Syndromes4
Disorders of Excessive Somnolence2
Cardiovascular Diseases1
Communication Disorders1
Diabetes Mellitus1
Narcolepsy1
Obesity1
Periodontal Diseases1
Sleep Apnea, Central1

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.